Vividion Therapeutics Funding & Investors
San Diego, CA
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
vividion.comTotal Amount Raised: $371,504,608
Vividion Therapeutics Funding Rounds
Series C
$135,000,000
Series C Investors
Boxer CapitalLogos Global ManagementArch Venture PartnersBiotechnology Value FundRa Capital ManagementVersant VenturesCasdin CapitalMubadala Capital VenturesDriehaus Capital ManagementNextech InvestSurveyor CapitalT. Rowe PriceAcuta Capital PartnersSoftBank Vision FundAvoro Capital Advisors (formerly venBio Select Advisor)Woodline PartnersSeries B
$82,000,000
Series B Investors
Nextech InvestCasdin CapitalTrinitas CapitalAltitude Life Science VenturesMubadala Capital VenturesAlexandriaMirae AssetBiotechnology Value FundVersant VenturesCardinal PartnersArch Venture PartnersCelgeneCorporate Round
$101,000,000
Corporate Round Investors
CelgeneSeries A
$50,000,000
Series A Investors
Arch Venture PartnersVersant VenturesCardinal PartnersSeries A
$3,504,616
Series A Investors
Cardinal Partners
Funding info provided by Diffbot.